Cambridge Investment Research Ltd Company Profile

17:36 EDT 18th March 2018 | BioPortfolio

CIR is here to help companies solve their problems and reach their goals. We like new ideas, modern ways of thinking. We won't work with companies unless we think we can help. We only take on projects where our goals are in line with those we work with. CIR set up and runs the high value, technology manufacturing event series (HVM Series). This is a powerful set of newstyle events with talks, expos, and marketplaces for technology companies, product makers and assemblers, and brand owners.


United Kingdom


Phone: 44 1223 303500

News Articles [1793 Associated News Articles listed on BioPortfolio]

Cambridge Investment Research Advisors Inc. Sells 5,586 Shares of McKesson Corporation

Cambridge Investment Research Advisors Inc. cut its holdings in shares of McKesson Corporation by 20.7% during the 3rd quarter, according to the company in its most recent filing with the Securities a...

#jobs #lifescience Research Associate III at Biotech/Pharma in Cambridge, MA

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Research Associate III at Biotech/Pharma in Cambridge, MA .MA-Cambridge, Rese...

#jobs #lifescience MedImmune: Research Scientist – (Cambridge)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MedImmune: Research Scientist – (Cambridge) . Negotiable: MedImmune: Re...

Private investment in Cavendish Laboratory secures next phase of new research facility in the UK

(Engineering and Physical Sciences Research Council) The government today confirmed a major £75 million investment in the Cavendish Laboratory at the University of Cambridge. Originally announced in ...

AI company buys Cambridge research facility to accelerate its drug research

BenevolentAI, a private artificial intelligence company, has acquired a state-of-the-art drug discovery and development facility on the Babraham Research Campus in Cambridge, UK

Professor Greg Hannon to Become Director of the Cancer Research UK Cambridge Institute

Cancer Research UK and the University of Cambridge are pleased to announce the appointment of Professor Greg Hannon as the new director of the Cancer Research UK Cambridge Institute, today (Thursday).

Cambridge Uni launches £42m NHS care research institute

The University of Cambridge is launching a new, £42-million research institute, tasked with gathering evidence to better support decisions on improving NHS care and organisation.

#jobs #lifescience Controller Cambridge Healthcare

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Controller Cambridge Healthcare .MA-Boston, A Cambridge-based healthcare firm...

PubMed Articles [1275 Associated PubMed Articles listed on BioPortfolio]

GP leader urges government to step up investment.

Translation research to apply genomics to improve health promotion: Is it worth the investment?

Better Open Than Intellectual: The Benefits of Investment Personality Traits for Learning.

The investment theory of adult intelligence posits that individual differences in knowledge attainment result from people's differences in cognitive ability and their propensity to apply and invest th...

Modeling the impact of transport energy consumption on CO2 emission in Pakistan: Evidence from ARDL approach.

The objective of this research is to examine the relationship between transport energy consumption, economic growth, and carbon dioxide emission (CO2) from transport sector incorporating foreign direc...

Social Return on Investment: A New Approach to Understanding and Advocating for Value in Healthcare.

To determine whether the methodology of social return on investment (SROI) could be a way in which the value of a healthcare-related program (children's cancer camp) could be captured, evaluated, and ...

Clinical Trials [1063 Associated Clinical Trials listed on BioPortfolio]

Determine Return on Investment in Heart Failure Remote Monitoring Program

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return ...

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

A three site study to evaluate the reproducibility of the Aina HbA1c Monitoring System in quantitative determination of glycosylated hemoglobin (HbA1c) took place at the following sites: ...

Color Vision as a Measure for Inherited Retinal Diseases

Background: - The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRD...

Mother-Child Relationships During Pregnancy Among Bofi Foragers

This study will examine changes in mother-child relationships when mothers are pregnant, because this period may involve conflicts between mothers and children. A widely held evolutionary...

Mayo AVC Registry and BioBank

Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death i...

Companies [2353 Associated Companies listed on BioPortfolio]

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test ...

Cambridge Biomedical, Inc.

Cambridge Biomedical is a contract research organization (CRO) and diagnostic laboratory providing bioanalytical support to the pharmaceutical, biotechnology, and medical d...

Funxional Therapeutics Limited

Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK) which focuses on novel anti-inflammatory therapies. FXT is managed by a very experienced t...

Edison Investment Research

Edison Investment Research is Europe’s leading investment research company. The team of more than 70 includes over 40 analysts supported by a department of supervisory analys...

Funxional Therapeutics

Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK). The Company focuses on the discovery and development of novel anti-infla...

More Information about "Cambridge Investment Research Ltd" on BioPortfolio

We have published hundreds of Cambridge Investment Research Ltd news stories on BioPortfolio along with dozens of Cambridge Investment Research Ltd Clinical Trials and PubMed Articles about Cambridge Investment Research Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge Investment Research Ltd Companies in our database. You can also find out about relevant Cambridge Investment Research Ltd Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record